Publications - 'E'
Publications 1976 - 2000 de 2582
| Titre | DOI |
|---|---|
|
Evans' Syndrome: From Diagnosis to Treatment S. Audia; N. Grienay; M. Mounier; M. Michel; B. Bonnotte 2020 |
10.3390/jcm9123851 |
|
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged >= 60 years: a systematic review and meta-analysis D. Hupin; F. Roche; V. Gremeaux; J.C. Chatard; M. Oriol; J.M. Gaspoz; J.C. Barthelemy; P. Edouard 2015 |
10.1136/bjsports-2014-094306 |
|
Even violins can cry: specifically vocal emotional behaviours also drive the perception of emotions in non-vocal music D. Bedoya; P. Arias; L. Rachman; M. Liuni; C. Canonne; L. Goupil; J.J. Aucouturier 2021 |
10.1098/rstb.2020.0396 |
|
Event horizons in nonlinear optics K.E. Webb; M. Erkintalo; Y.Q. Xu; N.G.R. Broderick; J.M. Dudley; G. Genty; S.G. Murdoch 2014 |
|
|
Event horizons in nonlinear optics K.E. Webb; M. Erkintalo; Y.Q. Xu; N.G.R. Broderick; J.M. Dudley; G. Genty; S.G. Murdoch 2014 |
|
|
Event Unit Analysis: A Methodology for Anticipating Processing Demands of Complex Animated Diagrams R. Lowe; J.M. Boucheix 2020 |
10.1007/978-3-030-54249-8_24 |
|
Event-B Specification of Transportation System in Dynamic Environment: Study of Urban Public Transportation System M. Garoui; B. Mazigh; B.El Ayeb; A. Koukam 2014 |
|
|
Event-B Specification of Transportation System in Dynamic Environment: Study of Urban Public Transportation System M. Garoui; B. Mazigh; B.El Ayeb; A. Koukam 2014 |
|
|
Event-Based Trajectory Prediction Using Spiking Neural Networks G. Debat; T. Chauhan; B.R. Cottereau; T. Masquelier; M. Paindavoine; R. Baures 2021 |
10.3389/fncom.2021.658764 |
|
Event-Related Potential Responses of Motorcyclists Towards Rear End Collision Warning System M. Muzammel; M.Zuki Yusoff; F. Meriaudeau 2018 |
10.1109/ACCESS.2018.2845899 |
|
Event-Related Potentials (ERP) Indices of Motivation during the Effort Expenditure for Reward Task J. Giustiniani; M. Nicolier; J.Teti Mayer; T. Chabin; C. Masse; N. Galmes; L. Pazart; B. Trojak; D. Bennabi; P. Vandel; E. Haffen; D. Gabriel 2020 |
10.3390/brainsci10050283 |
|
Everolimus (EVE) plus endocrine therapy in patients with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (BC): First-and second-line data from the BOLERO-4 study. F. Cardoso; C. Villanueva; M. Royce; F. Cruz; M. Debled; R. Hegg; T. Toyama; C.Isadora Falkson; J. Jeong; V. Srimuninnimit; M. Ozguroglu; W.John Gradishar; S.J. Azevedo; C.H. Arce; A. Ridolfi; C. Lin; T.Denis Bachelot 2017 |
10.1200/JCO.2017.35.15_suppl.1010 |
|
Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4 T. Bachelot; M. Royce; C. Villanueva; M. Cruz; R. Hegg; C. Falkson; J. Jeong; V. Srimuninnimit; C.H. Arce; A. Ridolfi; C. Lin; W. Gradishar; M. Ozguroglu; F. Cardoso; S. Azevedo 2017 |
|
|
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study T. Walter; C. Lepage; R. Coriat; E. Barbier; G. Cadiot; F.X. Caroli-Bosc; T. Aparicio; K. Bouhier-Leporrier; O. Hentic-Dhome; F. Gay; A.C. Dupont-Gossart; M. Duluc; C. Lepere; T. Lecomte; D. Smith; C. Petorin; F. Di-Fiore; F. Ghiringhelli; J.L. Legoux; R. Guimbaud; E. Baudin; C. Lombard-Bohas; T. de Baere; F.F.C.D.1104 Investigators 2019 |
10.1016/j.ejca.2019.09.021 |
|
Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study T. Walter; C. Lepage; R. Coriat; E. Barbier; G. Cadiot; F.X.Caroli Bosc; T. Aparicio; B. Leporrier; H. Dhome; A.C. Dupont-Gossart; M. Duluc; C. Lepere; T. Lecomte; D. Smith; C. Petorin; I. Caron; M.P. Ducreux; L. Bohas; T. De Baere 2018 |
|
|
Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study T. Walter; C. Lepage; R. Coriat; E. Barbier; G. Cadiot; F.X.Caroli Bosc; T. Aparicio; B. Leporrier; H. Dhome; A.C. Dupont-Gossart; M. Duluc; C. Lepere; T. Lecomte; D. Smith; C. Petorin; I. Caron; M.P. Ducreux; L. Bohas; T. De Baere 2018 |
|
|
Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study T. Walter; C. Lepage; R. Coriat; E. Barbier; G. Cadiot; F.X.Caroli Bosc; T. Aparicio; B. Leporrier; H. Dhome; A.C. Dupont-Gossart; M. Duluc; C. Lepere; T. Lecomte; D. Smith; C. Petorin; I. Caron; M.P. Ducreux; L. Bohas; T. De Baere 2018 |
|
|
Everolimus and sunitinib as first-and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Francais d'Etude des Tumeurs Uro-Genitales). C. Linassier; L. Albiges; C. Chevreau; B. Laguerre; S. Oudard; M. Gross-Goupil; G. Gravis; F. Goldwasser; F. Rolland; R. Delva; L. Moise; J.M. Tourani; C. Vassal; S. Zanetta; N. Penel; A. Flechon; C. Theodore; P. Barthelemy; C. Saldana; B. Escudier 2016 |
10.1200/jco.2016.34.2_suppl.505 |
|
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial M. Royce; T. Bachelot; C. Villanueva; M. Ozguroglu; S.J. Azevedo; F.Melo Cruz; M. Debled; R. Hegg; T. Toyama; C. Falkson; J. Jeong; V. Srimuninnimit; W.J. Gradishar; C. Arce; A. Ridolfi; C. Lin; F. Cardoso 2018 |
10.1001/jamaoncol.2018.0060 |
|
Everolimus trial in a refractory epilepsy case secondary to a PI3K-Akt-mTOR signaling pathway mosaic mutation: from physiopathological theory to clinical practice N. Hadouiri; V. Darmency; J. Riviere; L. Guibaud; A. Sorlin; V. Carmignac; J. Riviere; M. Luu; M. Bardou; C. Thauvin-Robinet; P. Vabres; L. Faivre 2019 |
|
|
Everolimus trial in a refractory epilepsy case secondary to a PI3K-Akt-mTOR signaling pathway mosaic mutation: from physiopathological theory to clinical practice N. Hadouiri; V. Darmency; J. Riviere; L. Guibaud; A. Sorlin; V. Carmignac; J. Riviere; M. Luu; M. Bardou; C. Thauvin-Robinet; P. Vabres; L. Faivre 2019 |
|
|
Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial D. Carrie; N. Delarche; C. Piot; J. Berland; N. Menneveau; L. Bonello; A. Py; E. Teiger; L. Leborgne; G. Bayet; O. Wittenberg; F. Schiele 2014 |
10.4244/EIJV10I6A122 |
|
Every triangle-free induced subgraph of the triangular lattice is (5m, 2m)-choosable Y. Aubry; J.C. Godin; O. Togni 2014 |
10.1016/j.dam.2013.09.028 |
|
Everyday life politics. Agenda and time table of a woman politician M. Navarre 2018 |
|
|
Everyday life politics. Agenda and time table of a woman politician M. Navarre 2018 |